Pharmacy |
| ||
|
Zarontin Generic Ethosuximide |
|
| ||
Home » Prescription Drugs 17 » Zarontin Generic Ethosuximide IndicationsZARONTIN is indicated for the control of petit mal epilepsy.This medication is used alone or with other medications to control certain types of seizure problems (e.g. absence or petit mal seizures). Controlling seizures helps to prevent injury from falling and allows you to lead a more normal life. Ethosuximide belongs to a class of drugs known as anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.Dosage and AdministrationZARONTIN is administered orally.Recommended initial daily dose for children and adults is approximately 20-30 mg/kg administered in two divided doses. This regimen will frequently achieve plasma levels in the therapeutic range of 40-100 mg/L. (Optimum 75 mg/L). As the dose serum level relationship may be curvilinear in individual patients dosage should be increased by small increments.One useful method is to increase the daily dose by 250 mg every four to seven days until control is achieved with minimal side effects. Dosages exceeding 1.5 g daily in divided doses should be administered only under the strictest supervision of the physician. Plasma level monitoring is recommended. ZARONTIN may be administered in combination with other anticonvulsants when other forms of epilepsy coexist with petit mal. Buy Zarontin Generic Ethosuximide and other Prescription Drugs 17 products online at Medstore. 5670
About Zarontin Generic Ethosuximide: Product Type: Prescription Drugs 17 Zarontin ( Generic Ethosuximide ) Zarontin (Generic Ethosuximide) Generic Ethosuximide 250mg 200 Tablets Generic Ethosuximide Zarontin
View more Prescription Drugs 17 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
